Filing Flows › Idexx Laboratories (IDXX) › Net income
Idexx Laboratories (IDXX) net income by quarter
Idexx Laboratories' net income was $317M in Q3 2026 (third quarter 2026), -6% from Q2 2026. Over the last 7 quarters it ranged from $243M (Q1 2025) to $338M (Q2 2026).
| Quarter | Net income | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $317M | -6% | +15% |
| Q2 2026 | $338M | +22% | +15% |
| Q1 2026 | $278M | +12% | +15% |
| Q4 2025 | $248M | -10% | — |
| Q3 2025 | $275M | -7% | — |
| Q2 2025 | $294M | +21% | — |
| Q1 2025 | $243M | — | — |
Q3 2026 at a glance
Idexx Laboratories, Q3 2026: revenue $1.2B (+10% year over year), operating margin 33.1%, net earnings $317M, operating cash flow $450M. The chart follows the revenue to costs, profit and cash.
Questions
What is Idexx Laboratories' net income?
Idexx Laboratories' net income was $317M in Q3 2026 (third quarter 2026), -6% from Q2 2026.
How has Idexx Laboratories' net income changed?
Over the last 7 quarters it ranged from $243M (Q1 2025) to $338M (Q2 2026).